Subcutaneous Drug Delivery Market, By Usability, By Disease Indication, By Delivery SystemBy Distribution Channel, and By Region

Description

Subcutaneous Drug Delivery Market is estimated to be valued at USD 15.70 Bn in 2026 and is expected to reach USD 30.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 15.70 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.90%	2033 Value Projection:	USD 30.41 Bn

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.

Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.

Market Dynamics

Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global subcutaneous drug delivery market based on the following parameters-company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

Global Subcutaneous Drug Delivery Market, Usability
Disposable
Reusable
Global Subcutaneous Drug Delivery Market, Disease Indication
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
Global Subcutaneous Drug Delivery Market, Delivery System
Prefilled Syringes
Autoinjector
- Spring Type
- Motorized Type
- Wearable Type
Pen Injectors
- Disposable
- Reusable
- Syringes (Injector)
Others (pump, etc.)
Global Subcutaneous Drug Delivery Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Subcutaneous Drug Delivery Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Becton Dickinson and Company,
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novo Nordisk A/S,
Johnson & Johnson
Novartis International AG
Amgen, Inc.
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG.,
Consort Medical plc,
Eli Lilly and Company
Merck & Co., Inc.
Insulet Corporation,
West Pharmaceutical Services, Inc.
Gerresheimer AG

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2933

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Usability
- Market Snapshot, By Disease Indication
- Market Snapshot, By Delivery System
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, and Collaborations
Product Launch
Regulatory Scenario
PEST Analysis

4. Global Subcutaneous Drug Delivery

Economic Impact
Impact on Supply and Demand

5. Global Subcutaneous Drug Delivery Market, By Usability, 2021€"2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Auto-immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Oncology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Hormonal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Allergy & Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Auto injector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Pen Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Others (pump, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

9. Global Subcutaneous Drug Delivery Market, By Region, 2021€"2033, (US$ Billion)

Overview
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Becton Dickinson and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novo Nordisk A/S
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Johnson & Johnson.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novartis International AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amgen, Inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- F. Hoffmann-La Roche AG.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Consort Medical plc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- LaVision Biotec GmbH
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Insulet Corporation
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- West Pharmaceutical Services, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Gerresheimer AG.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies

11. Section

References
Research Methodology
About us and Sales Contact